Sorafenib prolongs survival, but what happens to the symptoms?
- PMID: 22342632
- DOI: 10.1016/j.jhep.2012.01.023
Sorafenib prolongs survival, but what happens to the symptoms?
Comment on
-
Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?J Hepatol. 2012 Mar;56(3):686-95. doi: 10.1016/j.jhep.2011.07.031. Epub 2011 Oct 2. J Hepatol. 2012. PMID: 21971559 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical